Exploring the chemical space for potential inhibitors against cell surface binding protein of Mpox virus using

Dwaipayan Chaudhuri1, Satyabrata Majumder1, Joyeeta Datta1

  • 1Department of Life Sciences, Presidency University, Kolkata, India.

Insights

Researchers identified molecules that bind to the Mpox virus E8L protein, blocking viral entry. This discovery offers a promising strategy for developing new therapeutics against the Mpox virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Mpox virus, a member of the Poxviridae family, has caused global infections.
  • Poxviruses enter cells using glycosaminoglycans, such as chondroitin sulfate and heparan sulfate.
  • The Mpox virus E8L protein (cell surface binding protein) is critical for host cell attachment and viral entry.

Purpose of the Study:

  • To identify novel molecules that can inhibit Mpox virus infection.
  • To target the chondroitin sulfate binding groove of the E8L protein.
  • To develop potential therapeutics by outcompeting natural ligands for E8L binding.

Main Methods:

  • Structural analysis of the chondroitin sulfate binding groove in the Mpox virus E8L protein.
  • In silico identification of molecules structurally similar to chondroitin sulfate.
  • Evaluating the binding affinity of identified molecules to the E8L protein.

Main Results:

  • Molecules with higher binding affinity to the E8L protein's chondroitin sulfate binding groove were identified.
  • These molecules have the potential to block viral attachment and entry.
  • The study provides a foundation for developing novel anti-Mpox virus therapeutics.

Conclusions:

  • Targeting the E8L protein's binding pocket with high-affinity molecules is a viable therapeutic strategy.
  • This approach could lead to effective treatments to curb the spread of Mpox virus infections.
  • Further research may yield potent inhibitors for Mpox virus therapeutics.

Related Concept Videos